Windtree Therapeutics (WINT)
(Delayed Data from NSDQ)
$3.16 USD
-0.02 (-0.47%)
Updated Sep 16, 2024 03:56 PM ET
After-Market: $3.22 +0.07 (2.06%) 4:30 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Windtree Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.29 | -39.21 | -67.64 | -32.57 | -27.48 |
Depreciation/Amortization & Depletion | 3.14 | 19.98 | 45.21 | 0.17 | 0.36 |
Net Change from Assets/Liabilities | 2.02 | -1.78 | -0.06 | -1.33 | -6.71 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.70 | 1.56 | -1.18 | 8.41 | 9.16 |
Net Cash From Operating Activities | -13.44 | -19.45 | -23.66 | -25.32 | -24.66 |
Property & Equipment | -0.02 | 0.20 | -0.28 | -0.29 | -0.19 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 13.99 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.02 | 0.20 | -0.28 | -0.29 | 13.80 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 11.64 | 0.00 | 27.39 | 20.39 | 22.98 |
Issuance (Repayment) of Debt | -0.80 | -1.17 | -2.87 | -0.43 | -1.06 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.76 | 4.25 | 4.84 | 0.00 | -0.15 |
Net Cash from Financing Activities | 11.60 | 3.08 | 29.36 | 19.96 | 21.77 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.47 |
Net Change In Cash & Equivalents | -1.86 | -16.18 | 5.42 | -5.65 | 11.37 |
Cash at Beginning of Period | 6.33 | 22.50 | 17.08 | 22.73 | 11.36 |
Cash at End of Period | 4.47 | 6.33 | 22.50 | 17.08 | 22.73 |
Diluted Net EPS | -94.24 | -1,119.25 | -2,455.04 | -1,870.50 | -2,266.41 |
Fiscal Year End for Windtree Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -1.81 | 10.22 | -20.29 | -15.14 | -10.71 |
Depreciation/Amortization & Depletion | 0.11 | 0.02 | 3.14 | 3.12 | 3.10 |
Net Change from Assets/Liabilities | 2.90 | 1.19 | 2.02 | 1.12 | 0.80 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -6.47 | -14.38 | 1.70 | 1.03 | 0.80 |
Net Cash From Operating Activities | -5.27 | -2.95 | -13.44 | -9.87 | -6.02 |
Property & Equipment | -0.01 | 0.00 | -0.02 | -0.02 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | 0.00 | -0.02 | -0.02 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -0.07 | 0.00 | 11.64 | 11.64 | 11.64 |
Issuance (Repayment) of Debt | 1.08 | -0.23 | -0.80 | -0.56 | -0.33 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 1.62 | 1.27 | 0.76 | 0.00 | 0.00 |
Net Cash from Financing Activities | 2.63 | 1.03 | 11.60 | 11.07 | 11.31 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -2.66 | -1.91 | -1.86 | 1.19 | 5.29 |
Cash at Beginning of Period | 4.47 | 4.47 | 6.33 | 6.33 | 6.33 |
Cash at End of Period | 1.81 | 2.56 | 4.47 | 7.52 | 11.62 |
Diluted Net EPS | -20.91 | 21.98 | 36.33 | -15.47 | -29.50 |